115 related articles for article (PubMed ID: 9413194)
1. Comparison of the effects of epidermal growth factor and fetal calf serum in human endometrial carcinoma RL95-2 cells.
Sallot M; Lascombe I; Bermont L; Jouvenot M
Anticancer Res; 1997; 17(5A):3499-504. PubMed ID: 9413194
[TBL] [Abstract][Full Text] [Related]
2. Differential EGF action on nuclear protooncogenes in human endometrial carcinoma RL95-2 cells.
Sallot M; Ordener C; Lascombe I; Propper A; Adessi GL; Jouvenot M
Anticancer Res; 1996; 16(1):401-6. PubMed ID: 8615644
[TBL] [Abstract][Full Text] [Related]
3. Proliferation of the human colon carcinoma cell line HT29: autocrine growth and deregulated expression of the c-myc oncogene.
Forgue-Lafitte ME; Coudray AM; Bréant B; Mester J
Cancer Res; 1989 Dec; 49(23):6566-71. PubMed ID: 2684395
[TBL] [Abstract][Full Text] [Related]
4. Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells.
Kimura S; Maekawa T; Hirakawa K; Murakami A; Abe T
Cancer Res; 1995 Mar; 55(6):1379-84. PubMed ID: 7882339
[TBL] [Abstract][Full Text] [Related]
5. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines.
Li BD; Budnick RM; Russo CA; Anderson GR; Stewart CC
J Surg Res; 1995 Oct; 59(4):485-92. PubMed ID: 7564322
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor stimulates proliferation of human osteosarcoma cells and accumulation of c-myc messenger RNA.
Kirstein M; Baglioni C
J Cell Physiol; 1988 Mar; 134(3):479-84. PubMed ID: 2450880
[TBL] [Abstract][Full Text] [Related]
7. Effect of epidermal growth factor on the expression of protooncogenes c-myc and c-Ha-ras in short-term primary hepatocyte culture.
Kost DP; Michalopoulos GK
J Cell Physiol; 1990 Jul; 144(1):122-7. PubMed ID: 2195043
[TBL] [Abstract][Full Text] [Related]
8. Phosphorothioated antisense c-myc oligonucleotide inhibits the growth of human colon carcinoma cells.
Yu BW; Nguyen D; Anderson S; Allegra CA
Anticancer Res; 1997; 17(6D):4407-13. PubMed ID: 9494542
[TBL] [Abstract][Full Text] [Related]
9. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
Chavany C; Connell Y; Neckers L
Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
[TBL] [Abstract][Full Text] [Related]
10. Daily addition of an anti-c-myc DNA oligomer induces granulocytic differentiation of human promyelocytic leukemia HL-60 cells in both serum-containing and serum-free media.
Bacon TA; Wickstrom E
Oncogene Res; 1991; 6(1):21-32. PubMed ID: 1997946
[TBL] [Abstract][Full Text] [Related]
11. EGF promotes development of a differentiated trophoblast phenotype having c-myc and junB proto-oncogene activation.
Dakour J; Li H; Chen H; Morrish DW
Placenta; 1999 Jan; 20(1):119-26. PubMed ID: 9950153
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
Nass SJ; Dickson RB
Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
14. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
Ginobbi P; Geiser TA; Ombres D; Citro G
Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
[TBL] [Abstract][Full Text] [Related]
15. Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines.
Cerutti J; Trapasso F; Battaglia C; Zhang L; Martelli ML; Visconti R; Berlingieri MT; Fagin JA; Santoro M; Fusco A
Clin Cancer Res; 1996 Jan; 2(1):119-26. PubMed ID: 9816098
[TBL] [Abstract][Full Text] [Related]
16. Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line.
Rosolen A; Whitesell L; Ikegaki N; Kennett RH; Neckers LM
Cancer Res; 1990 Oct; 50(19):6316-22. PubMed ID: 2205380
[TBL] [Abstract][Full Text] [Related]
17. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM
Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061
[TBL] [Abstract][Full Text] [Related]
18. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
[TBL] [Abstract][Full Text] [Related]
19. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G
Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
